My ePortfolio Register   

WIN Symposium 2017 /
Genomic predictors of treatment response in prostate cancer

26th - 27th Jun 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.07.17
Views: 559

Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada

Dr Bristow speaks with ecancer at WIN 2017 about trials ongoing with patients in the Canadian Prostate Cancer Genome Network (CPC-GENE) to determine patient subgroups most at risk of disease progression and drug resistance.

He notes the use of imaging to guide treatment and gauge response, and considers the significance of the abiraterone data from earlier this year at ASCO 2017.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence